"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...

Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...

Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP).

The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...